Key Presentations at JPM25: AbbVie, UCB, WuXi Biologics Highlight Industry Trends
JPM25 Conference:
The 43rd Annual J.P. Morgan Healthcare Conference (JPM25) is taking place from January 13-16, 2025, in San Francisco, CA, featuring presentations from leading companies like AbbVie, UCB, and WuXi Biologics134.
Industry Trends:
Key themes for 2025 include M&A, driven by improved balance sheets and the upcoming 2028 and 2029 patent cliff, as well as innovation in areas like obesity, inflammation and immunology, oncology, and cardio renal metabolic1.
WuXi Biologics Presentation:
WuXi Biologics highlighted its CRDMO model for global success, emphasizing end-to-end services that enable and expedite innovations to meet client needs, with a focus on accelerated growth in 20252.
Biotech Focus:
The conference emphasizes the importance of innovation in biotech, with new drug launches and strategic interest in therapeutic areas like I&I, oncology, and cardio renal metabolic expected to be significant in 20251.
Berkeley Bio Startup Showcase:
The Berkeley Life Sciences Entrepreneurship Center (LSEC) is hosting the Berkeley Bio Startup Showcase on January 14, 2025, to showcase innovations from UC Berkeley startups in the biotech industry5.
Sources:
1. https://www.jpmorgan.com/about-us/events-conferences/health-care-conference
2. https://www.marketscreener.com/quote/stock/WUXI-BIOLOGICS-CAYMAN-INC-37230806/news/WuXi-Biologics-Cayman-43rd-Annual-J-P-Morgan-Healthcare-Conference-Presentation-48743985/
3. https://deal.town/questex/011525-lilly-overestimates-glp-1-market-in-q4-gsk-sanofi-ceos-welcome-vaccine-efficacy-discussions-F3CFRDQTUKCY